<code id='6CD63ABB31'></code><style id='6CD63ABB31'></style>
    • <acronym id='6CD63ABB31'></acronym>
      <center id='6CD63ABB31'><center id='6CD63ABB31'><tfoot id='6CD63ABB31'></tfoot></center><abbr id='6CD63ABB31'><dir id='6CD63ABB31'><tfoot id='6CD63ABB31'></tfoot><noframes id='6CD63ABB31'>

    • <optgroup id='6CD63ABB31'><strike id='6CD63ABB31'><sup id='6CD63ABB31'></sup></strike><code id='6CD63ABB31'></code></optgroup>
        1. <b id='6CD63ABB31'><label id='6CD63ABB31'><select id='6CD63ABB31'><dt id='6CD63ABB31'><span id='6CD63ABB31'></span></dt></select></label></b><u id='6CD63ABB31'></u>
          <i id='6CD63ABB31'><strike id='6CD63ABB31'><tt id='6CD63ABB31'><pre id='6CD63ABB31'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:7211

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

          How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

          advertisement

          STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

          Featured speakers:

          • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
          • Ramita Tandon, chief clinical trials officer, Walgreens
          • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
          • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
          • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

          Sponsored By

          OneStudyTeam

           

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          For one rare type of lung cancer, Pfizer pill reduces progression by 81%
          For one rare type of lung cancer, Pfizer pill reduces progression by 81%

          AP/BusinessWireTherearealotofreasonswhyupdateddataonPfizer’sLorbrena,atreatmentfornon-smallcelllungc

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          6 solutions to address cancer drug shortages and others

          GeorgeFrey/GettyImagesWASHINGTON—RepublicansandDemocratsalikewanttostopdrugshortagesfromhappening.Th